MR编号 | DK/H/3168/001 |
---|
药品名称 | Wynzora |
---|
活性成分 | - Betamethasone dipropionate 0.5 mg
- Calcipotriol 50.0 µg
|
---|
剂型 | Cream |
---|
上市许可持有人 | Almirall S.A.
Ronda General Mitre 151,
08022 Barcelona, Spain
Denmark |
---|
参考成员国 - 产品名称 | Denmark (DK) Wynzora |
---|
互认成员国 - 产品名称 | - Poland (PL)
Wynzora - Germany (DE)
Wynzora 50 Mikrogramm/g + 0,5 mg/g Creme - Czechia (CZ)
Wynzora, 50 mikrogramů/g + 0.5 mg/g krém - Netherlands (NL)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
- Belgium (BE)
- Finland (FI)
- Luxembourg (LU)
|
---|
许可日期 | 2021/06/29 |
---|
最近更新日期 | 2025/01/15 |
---|
药物ATC编码 | - D05AX52 calcipotriol, combinations
|
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|